The potter Nanak and his son · Kehar Singh, 19th century · Public domain
0

Generic and branded medicine prices in India: the gap

“Know what a prescribed medicine costs and how prices compare”

The Union Health Ministry says households paid 43.4% of India's health spending out of pocket in 2022-23, down from 64.2% in 2013-14 but above 39.4% in 2021-22.

Compiled by the Takṣa team from public reportsLast updated 10 October 2026

The problem

The Union Health Ministry released the National Health Accounts estimates for 2022-23 on 27 May 2026. They put out-of-pocket spending at 43.4% of total health expenditure in 2022-23, down from 64.2% in 2013-14. The same release says the share had dipped to 39.4% in 2021-22, which it ties to one-time government spending during the pandemic, so the 2022-23 figure is higher than the year before. A 2025 peer-reviewed paper in Frontiers in Public Health says, citing earlier studies, that medicines are the largest part of this burden, and more than half of household healthcare spending in some states.

The government's answer is the Jan Aushadhi scheme. The Ministry of Chemicals and Fertilizers described the pricing principle in 2022 as follows: a medicine is priced at no more than half the average price of the top three brands. The ministry said then that its medicines are cheaper at least by 50% and in some cases by 80% to 90%. A PIB backgrounder in March 2026 said over 18,000 Kendras sell generics generally 50-80% lower than comparable branded medicines. The same Frontiers paper compared 696 eye and ENT products, with brand prices from late 2021. The paper reports the Jan Aushadhi price for eye medicines as 69 percent higher than branded drugs, in a section on the minimum branded price, without saying how the figure was calculated. The ENT comparison covered seven Jan Aushadhi drugs and 137 brands. Its authors wrote that not all generic drugs are uniformly cheaper than their branded counterparts. The paper's abstract also says most of the Jan Aushadhi medicines it examined met the WHO affordability threshold, while chronic treatments such as glaucoma drugs remained a burden for low-income households. That is one study, mostly of eye and ENT products, not a finding about all medicines.

The Solved elsewhere tab describes a government app for finding generics. The PIB backgrounder does not say whether it matches the brand written on a prescription, so we cannot say whether it helps a patient with a prescription find the matching generic.

We compiled this page from public sources. We did not contact the Pharmaceuticals and Medical Devices Bureau of India, the Health Ministry or the paper's authors. We did not compare any prices ourselves or visit a Kendra, so we have not checked whether one stocks a given medicine. The 50-80% and 18,000 figures are the government's own and were not independently checked. This page is not medical advice.

Who has this problem
Households that pay for medicines out of their own pocket.